January 7, 2021

Outcomes of COVID-19 in Hospitalized Solid Organ Transplant Recipients Compared to a Matched Cohort of Non-Transplant Patients at a National Healthcare System in the United States

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): clinical characteristics

Solid organ transplant (SOT) recipients with COVID-19 were more likely to experience adverse outcomes than matched non-SOT recipients in a cohort study conducted between March and September 2020. SOT recipients (n=128) were 1.9 times more likely to die within the study period compared to non-SOT patients (n=3,907). SOT recipients were also more than twice as likely to receive invasive mechanical ventilation, develop acute kidney injury, or receive vasopressor support during hospitalization.

Fisher et al. (Jan 6, 2021). Outcomes of COVID-19 in Hospitalized Solid Organ Transplant Recipients Compared to a Matched Cohort of Non-Transplant Patients at a National Healthcare System in the United States. Clinical Transplantation. https://pubmed.ncbi.nlm.nih.gov/33406279/